Fig. 2From: Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort studyBiomarkers levels during relapse. a Calprotectin serum levels during relapse. b TNFi trough serum levels during relapseBack to article page